Skip Page Header

Home > Civil society monitoring of harm reduction in Europe, 2020: data report.

Rigoni, Rafaela and Tammi, Tuukka and van der Gouwe, Daan and Oberzil, Victoria and Csak, Robert and Schatz, Eberhard (2021) Civil society monitoring of harm reduction in Europe, 2020: data report. Amsterdam: Correlation – European Harm Reduction Network.

[img]
Preview
PDF (Civil society monitoring of harm reduction in Europe, 2020 - data report)
4MB
[img]
Preview
PDF (Civil society monitoring of harm reduction in Europe, 2020 - Summary)
436kB

This is the second civil society-led monitoring report produced by Correlation – European Harm Reduction Network (C-EHRN) within the context of our operational grant from the European Commission. The purpose of this report is to enrich the information and knowledge base of harm reduction interventions in Europe from the viewpoint of civil society organisations. We believe that this approach is a necessary, and useful, contribution to the development of drug policy in the region. 

We learned a lot from the former process and the 2019 edition and modified the approach, the focus and certain questions to enable respondents to report closer to their own experiences. Consequently, the information provided in this report sometimes represents the situation in a particular city or region and informs us as to the experiences of a specific organisation in the field. Such ‘real life’ information can contribute significantly to an understanding of the advantages, barriers and challenges of drug policy. Even stronger, we directly approached representatives of networks and organizations of people who use drugs to share their view on the developments with us. 2020, however, was not a regular year and the world wide pandemic had its influence on people, organisations and the care system in general. Accordingly, we added a section on the impact of COVID-19 on harm reduction services and we will continue to measure this impact. We will use the insights and information collected in this report within our advocacy efforts to strengthen harm reduction policies in Europe and, we hope, our partners and contributors will do the same in their environment at a regional and national level.

Repository Staff Only: item control page